Literature DB >> 21590308

Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases.

Florian Puls1, Clemens Agne, Fritz Klein, Martin Koch, Kinan Rifai, Michael P Manns, Jürgen Borlak, Hans H Kreipe.   

Abstract

Drug-induced liver injury may cause impairment of liver function and is a leading cause of acute liver failure. Identification of the causative substance in patients receiving several drugs is often difficult in clinical practice. Evaluation of liver biopsies in suspected drug-induced injury is a challenging task that requires close clinico-pathological correlation. Recognizing a characteristic morphological pattern of liver injury may contribute to identification of the causative drug. Flupirtine, a non-opioid analgesic, has been reported to cause liver injury of idiosyncratic type in rare instances. We wished to characterize the histopathological features of flupirtine-induced liver injury, which have not been reported so far. Liver biopsies of five patients with severe liver injury and one explanted liver of a patient with flupirtine-induced acute liver failure that required transplantation were assessed. In addition clinical presentation and course were reviewed and clinical follow up was performed. Extensive perivenular necrosis with associated ceroid pigment-laden macrophages and a mild to moderate lymphocytic infiltrate was a common feature in all cases. Histological extent of liver necrosis corresponded well to serum amino-transferase levels. Accidental reexposure of one patient resulted in a plasma cell rich hepatitis with perivenular necrosis. This study provides evidence that flupirtine can cause substantial liver injury of hepatocellular type. Liver damage is associated with a characteristic morphological picture, the recognition of which will aid in causality assessment of drug-induced liver injury. Clinical and histological features raise the possibility of an immune-mediated toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21590308     DOI: 10.1007/s00428-011-1087-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  27 in total

1.  Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.

Authors:  Syed H Hussaini; Ciara S O'Brien; Edward J Despott; Harry R Dalton
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-01       Impact factor: 2.566

2.  [Analgesic and muscle tonus normalizing effect of flupirtine retard in chronic back pain].

Authors:  G H H Müller-Schwefe; M A Uberall
Journal:  MMW Fortschr Med       Date:  2007-10-25

3.  Flupirtine-induced hepatic failure requiring orthotopic liver transplant.

Authors:  Fritz Klein; Matthias Glanemann; Birgit Rudolph; Daniel Seehofer; Peter Neuhaus
Journal:  Exp Clin Transplant       Date:  2011-08       Impact factor: 0.945

4.  Immune mechanisms in tienilic acid associated hepatotoxicity.

Authors:  J Neuberger; R Williams
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

5.  Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions.

Authors:  A T Banks; H J Zimmerman; K G Ishak; J G Harter
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

Review 6.  Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.

Authors:  H A Friedel; A Fitton
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

Review 7.  The pathology of drug-induced liver injury.

Authors:  David E Kleiner
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115

Review 8.  Histological patterns in drug-induced liver disease.

Authors:  R Ramachandran; S Kakar
Journal:  J Clin Pathol       Date:  2009-06       Impact factor: 3.411

9.  [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans].

Authors:  P Hlavica; G Niebch
Journal:  Arzneimittelforschung       Date:  1985

10.  [Acute treatment of episodic childhood tension-type headache with flupirtine and paracetamol - a double-blind crossover-study].

Authors:  R Pothmann; M Lobisch
Journal:  Schmerz       Date:  2000-02       Impact factor: 1.107

View more
  13 in total

1.  Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.

Authors:  Martin C Michel; Piotr Radziszewski; Christian Falconer; Daniela Marschall-Kehrel; Koenraad Blot
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

Authors:  Werner Siegmund; Christiane Modess; Eberhard Scheuch; Karen Methling; Markus Keiser; Ali Nassif; Dieter Rosskopf; Patrick J Bednarski; Jürgen Borlak; Bernd Terhaag
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

3.  Flupirtine drug-induced liver injury in a patient developing acute liver failure.

Authors:  David Noiva Perdigoto; Pedro Amaro; Manuela Ferreira; Luis Tomé
Journal:  BMJ Case Rep       Date:  2018-03-09

Review 4.  Non-Specific Low Back Pain.

Authors:  Jean-François Chenot; Bernhard Greitemann; Bernd Kladny; Frank Petzke; Michael Pfingsten; Susanne Gabriele Schorr
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

5.  Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.

Authors:  Kathleen Köck; Brian C Ferslew; Ida Netterberg; Kyunghee Yang; Thomas J Urban; Peter W Swaan; Paul W Stewart; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-10-23       Impact factor: 3.922

Review 6.  [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  C Sommer; W Häuser; R Alten; F Petzke; M Späth; T Tölle; N Uçeyler; A Winkelmann; E Winter; K J Bär
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

7.  Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation.

Authors:  Konrad W Wurm; Frieda-Marie Bartz; Lukas Schulig; Anja Bodtke; Patrick J Bednarski; Andreas Link
Journal:  ChemMedChem       Date:  2022-07-07       Impact factor: 3.540

8.  Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.

Authors:  Antonios Douros; Elisabeth Bronder; Frank Andersohn; Andreas Klimpel; Michael Thomae; Hans-Dieter Orzechowski; Reinhold Kreutz; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2013-12-24       Impact factor: 2.953

Review 9.  PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches.

Authors:  Jingheng Wang; Monicah Bwayi; Rebecca R Florke Gee; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-06-16       Impact factor: 4.481

Review 10.  Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Niklas Huntemann; Leoni Rolfes; Marc Pawlitzki; Tobias Ruck; Steffen Pfeuffer; Heinz Wiendl; Sven G Meuth
Journal:  Drugs       Date:  2021-06-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.